Logo Logo

Publications by Thiel, U.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 4.

Journal article

Thiel, U.; Blaeschke, F.; Richter, G.; Burdach, S. (2016): Human HLA-A*02:01/CHM1+allo-restricted T cell receptor-transgenic CD8+T cells specifically inhibit Ewing sarcoma growth in vitro and in vivo. In: European Journal of Cancer, Vol. 69: S51-S51

Schirmer, D.; Grünewald, T.; Klar, R.; Schmidt, O.; Wohlleber, D.; Alba Rubío, R.; Uckert, W.; Thiel, U.; Protzer, U.; Busch, D.; Krackhardt, A.; Burdach, S.; Richter, G. (2016): Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize and kill tumor associated antigen STEAP1+tumour cells in vivo. In: European Journal of Cancer, Vol. 69: S93-S93

Thiel, U.; Blaeschke, F.; Richter, G.; Grünewald, T.; Busch, D.; Alba Rubio, R.; Thiede, M.; Kirschner, A.; Pirson, S.; Mall, S.; Klar, R.; Leisegang, M.; Krackhardt, A.; Uckert, W.; Riddell, S.; Burdach, S. (2016): Human T Cell Receptor transgenic CD8(+) T cells specifically kill HLA-A*0201/CHM1(+) Ewing Sarcoma Lines in vitro and in a preclinical Mouse Model. In: Oncology Research and Treatment, Vol. 39: p. 147

Thiel, U.; Teichert von Luettichau, L.; Wawer, A.; Bender, H.-U.; Blaeschke, F.; Grünewaid, T.; Steinborn, M.; Bader, P.; Röper, B.; Bönig, H.; Klingebiel, T.; Koscielniak, E.; Dirksen, U.; Juergens, H.; Kolb, H.; Burdach, S. (2016): Stem cell rescue after irradiation of multiple tumor sites combined with high-dose chemotherapy - high long-term survival in patients with advanced translocation positive pediatric sarcomas without bone marrow involvement. In: Oncology Research and Treatment, Vol. 39: p. 39

This list was generated on Sun Dec 8 08:39:59 2019 CET.